| pubmed-article:3368993 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3368993 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:3368993 | lifeskim:mentions | umls-concept:C0011119 | lld:lifeskim |
| pubmed-article:3368993 | lifeskim:mentions | umls-concept:C0016340 | lld:lifeskim |
| pubmed-article:3368993 | lifeskim:mentions | umls-concept:C0014020 | lld:lifeskim |
| pubmed-article:3368993 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:3368993 | pubmed:dateCreated | 1988-6-13 | lld:pubmed |
| pubmed-article:3368993 | pubmed:abstractText | Decompression sickness is caused by the production of tissue and blood stream inert gas bubbles. Perfluorocarbon emulsions (PFC) have enhanced O2 and N2 solubilities as well as a small particle size as properties. The effects of treatment with a PFC (FC-43) and 100% oxygen on decompression sickness were investigated in 24 Sprague-Dawley rats compressed to 6.8 ATA and rapidly decompressed. Survival in animals receiving PFC and 100% oxygen was significantly longer (P = 0.01) than in those receiving a 6% hetastarch (H) treatment. The PFC survivors at 24 h did not demonstrate any neurologic deficits, whereas the 1 H animal surviving at 24 h was ataxic and not eating. Those animals who died most often did so within minutes after decompression, suggesting a hemodynamic demise. We conclude that PFC treatment when coupled with 100% oxygen breathing provides both hemodynamic and neurologic protection from decompression sickness. | lld:pubmed |
| pubmed-article:3368993 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3368993 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3368993 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:3368993 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3368993 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3368993 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3368993 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3368993 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:3368993 | pubmed:issn | 0093-5387 | lld:pubmed |
| pubmed-article:3368993 | pubmed:author | pubmed-author:IvankovichA... | lld:pubmed |
| pubmed-article:3368993 | pubmed:author | pubmed-author:SpiessB DBD | lld:pubmed |
| pubmed-article:3368993 | pubmed:author | pubmed-author:McCarthyR JRJ | lld:pubmed |
| pubmed-article:3368993 | pubmed:author | pubmed-author:TumanK JKJ | lld:pubmed |
| pubmed-article:3368993 | pubmed:author | pubmed-author:WoronowiczA... | lld:pubmed |
| pubmed-article:3368993 | pubmed:author | pubmed-author:ToolK AKA | lld:pubmed |
| pubmed-article:3368993 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3368993 | pubmed:volume | 15 | lld:pubmed |
| pubmed-article:3368993 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3368993 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3368993 | pubmed:pagination | 31-7 | lld:pubmed |
| pubmed-article:3368993 | pubmed:dateRevised | 2003-11-14 | lld:pubmed |
| pubmed-article:3368993 | pubmed:meshHeading | pubmed-meshheading:3368993-... | lld:pubmed |
| pubmed-article:3368993 | pubmed:meshHeading | pubmed-meshheading:3368993-... | lld:pubmed |
| pubmed-article:3368993 | pubmed:meshHeading | pubmed-meshheading:3368993-... | lld:pubmed |
| pubmed-article:3368993 | pubmed:meshHeading | pubmed-meshheading:3368993-... | lld:pubmed |
| pubmed-article:3368993 | pubmed:meshHeading | pubmed-meshheading:3368993-... | lld:pubmed |
| pubmed-article:3368993 | pubmed:meshHeading | pubmed-meshheading:3368993-... | lld:pubmed |
| pubmed-article:3368993 | pubmed:meshHeading | pubmed-meshheading:3368993-... | lld:pubmed |
| pubmed-article:3368993 | pubmed:meshHeading | pubmed-meshheading:3368993-... | lld:pubmed |
| pubmed-article:3368993 | pubmed:meshHeading | pubmed-meshheading:3368993-... | lld:pubmed |
| pubmed-article:3368993 | pubmed:year | 1988 | lld:pubmed |
| pubmed-article:3368993 | pubmed:articleTitle | Treatment of decompression sickness with a perfluorocarbon emulsion (FC-43). | lld:pubmed |
| pubmed-article:3368993 | pubmed:affiliation | Department of Anesthesia, Rush Presbyterian-St. Luke's Medical Center, Chicago, IL 60612. | lld:pubmed |
| pubmed-article:3368993 | pubmed:publicationType | Journal Article | lld:pubmed |
